Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Association between diffuse F18-FDG thyroid uptake and thyroid dysfunction

Eric Wideburg and Dan Bucklan
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2666;
Eric Wideburg
1Medical College of Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Bucklan
1Medical College of Wisconsin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2666

Introduction: F18-fluorodeoxyglucose (F18-FDG) positron emission tomography is a powerful tool most commonly utilized in oncologic imaging. F18-FDG is a glucose analog, preferentially absorbed by hypermetabolic tissues, the presence of which suggests the possibility of neoplasm. However, F18-FDG uptake is not specific to malignancy and is also seen in different physiologic, inflammatory, or infectious processes. A commonly detected abnormality is the presence of diffuse radiotracer uptake throughout the thyroid, which has been associated with an increased risk of thyroid dysfunction. The primary goal of this retrospective study was to determine the percentage of people in the study population who demonstrate diffuse F-18 FDG thyroid uptake and thyroid dysfunction, compare radiotracer uptake to a randomly selected population without thyroid dysfunction, and determine if there are different degrees of radiotracer uptake for different causes of thyroid dysfunction.

Methods: In this retrospective study, the Froedtert and MCW imaging database was used to identify patients with diffuse thyroid F18-FDG uptake on PET from May 2016 through May 2021. A total of 78 PET reports were identified, belonging to a total of 45 different patients. The imaging database was also used to randomly identify 10 patients with normal thyroid uptake during this same period. 11 patients were excluded from the study due to either inaccurate characterization of the thyroid related imaging findings or insufficient clinical data.

Multiple data points were collected from each PET and the patients’ electronic health records were reviewed for evidence of thyroid dysfunction. The 34 patients with diffusely increased radiotracer uptake in the thyroid were grouped into those with documented thyroid dysfunction and those without any apparent evidence of thyroid dysfunction. These groups were used to calculate the prevalence of thyroid dysfunction in the sample population. The ratio of maximum thyroid SUV to background liver maximum SUV was measured in all 31 patients with documented underlying thyroid dysfunction, and this was compared to a randomly selected control group of patients with no evidence of thyroid dysfunction.

Results: 34 patients were included in the study analysis, 31 of whom were determined to have a documented history of thyroid dysfunction. The average thyroid to liver uptake ratio in the population of individuals with thyroid dysfunction (M=2.22, SD=0.21) was significantly higher than the average uptake ratio in the control population without thyroid disease (M=0.48, SD 0.11), with a statistically significant difference in the means of the two populations; t(33)=10.07, p<0.01). The average uptake ratios in the different subgroups of patients with thyroid dysfunction were calculated, but the small number of patients in the different subgroups precluded any statistically significant results.

It was noted that using a thyroid to liver uptake ratio of 1 as a cutoff to suggest the possibility of thyroid dysfunction would accurately characterize the presence or absence of thyroid dysfunction in 41/44 patients in this study.

Conclusions: Subjects with diffusely increased radiotracer uptake in the thyroid have a high rate of underlying thyroid dysfunction, calculated at 91% in our sample population. The population of patients with underlying thyroid dysfunction demonstrated a statistically significant elevation in the ratio of thyroid to liver radiotracer uptake compared to the control group without thyroid dysfunction. The data from this study suggest that using a cutoff of thyroid to liver uptake ratio of 1.0 could be utilized to suggest underlying thyroid dysfunction, which applied retrospectively would have accurately characterized 93% of cases being assessed in this study.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association between diffuse F18-FDG thyroid uptake and thyroid dysfunction
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Association between diffuse F18-FDG thyroid uptake and thyroid dysfunction
Eric Wideburg, Dan Bucklan
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2666;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Association between diffuse F18-FDG thyroid uptake and thyroid dysfunction
Eric Wideburg, Dan Bucklan
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2666;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • COMMON PEDIATRIC NUCLEAR MEDICINE IMAGING STUDIES: A COMPREHENSIVE REVIEW
  • COVID-19 and Nuclear Medicine: what we know so far…
  • Utility of Depth Correction Calculator for Split Renal Function Studies utilizing prior CT or MRI
Show more General Clinical Specialties

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire